A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...

Like an estimated 20 million Americans, I have an incurable post-acute infection syndrome that goes by the name of long Covid ...

The lung cancer screening system “is not a risk assessment. It is a judgment system designed as one,” writes the director of ...

A federal commission is calling for significant changes to the way the U.S. government funds and assesses scientific research ...

With backlash growing to surging health insurance costs, Trump is floating a temporary extension of extra ACA subsidies.

Friends…hello. I’m BACK. My wife and I welcomed a new baby a few months ago. We now have two kids (still weird to say kids, ...

Medicare officials have backed off a plan that would have clawed back $7.8 billion from hospitals a decade sooner than originally planned.

Novo Nordisk said this morning that a pair of large, placebo-controlled clinical trials testing an oral version of its GLP-1 ...

A promising Alzheimer’s treatment failed to slow the progress of the disease, news that could dampen enthusiasm for a new class of potential medicines.

Novo Nordisk’s weight loss drug semaglutide failed to slow the progression of Alzheimer’s disease in two large trials ...

STAT’s Eric Boodman visited Healthy Start case manager Malaika Milele Gardner in New Orleans recently, spending time with her ...

Novo Nordisk's blockbuster weight loss drug semaglutide failed to slow Alzheimer's progression in trials. The studies had ...